RBC Capital Markets Upgrades Church & Dwight: A Strategic Bounce-Back Opportunity After Recent Decline

RBC Capital Markets has positioned Church & Dwight (NYSE: CHD) as a timely investable entity following a recent downturn. According to their analysis, the company appears poised for a bounce-back, suggesting that concerns over tariffs and consumer sentiment may be subsiding.

Analyst Nik Modi, in a notable upgrade, raised the rating of this consumer goods powerhouse from "sector perform" to "outperform," bumping up the price target by $14 to reach $114. This target implies a potential 16% increase from its last closing price. Just to paint the picture, Church & Dwight, known for its popular brands like Arm & Hammer and Nair, experienced a 7% drop on May 1 due to lackluster guidance for the second quarter. So far this year, the stock has declined by 6%. However, after assessing the company's prospects, Modi believes the current price marks a favorable entry point for savvy investors.

Modi explained that the company's shares had lagged behind the Consumer Staples Select Sector SPDR Fund (XLP) throughout 2025. He attributed this underperformance to a disappointing first quarter, affected by destocking and sluggish category growth after the imposition of tariffs. However, Modi expressed renewed confidence in Church & Dwight's ability to navigate these challenges after engaging with the company's management team, including the CEO and the new CFO. He believes that the company's guidance adequately reflects the prevailing challenges while maintaining bright prospects for market share growth across its product lines, particularly in laundry detergent, mouthwash, and skincare products.

Moreover, there's an exciting twist with Church & Dwight's recent acquisition of Touchland, a hand sanitizer brand. Modi views this as a significant move that could unlock new distribution channels and enhance revenue synergy with retail partner Sephora. He emphasized that this acquisition resembles the successful ones of recent years, like Hero and TheraBreath, rather than less favorable past deals, such as Flawless or Vitafusion. It seems the acquisition could very well provide a jolt of momentum moving forward.

Despite RBC's optimism, it's worth noting that the broader analyst community has mixed feelings about Church & Dwight. Out of 24 analysts covering the stock, only eight have issued 'strong buy' or 'buy' ratings, while 11 have chosen to maintain a 'hold' rating. The remaining five analysts have expressed reservations, categorizing the stock as underperform or sell. For traders, this divergence of opinion may highlight the potential for both risk and opportunity in the coming weeks.

As always, it's essential for investors to weigh these insights carefully and consider their own strategies when thinking about engaging with Church & Dwight's stock.